This review examines how interleukin cytokines influence neuroinflammation in Alzheimer's disease, highlighting potential therapeutic strategies.
Key Points
Interleukin cytokines may have both protective and detrimental roles in Alzheimer's disease, indicating a complex balance within the immune response.
The upregulation of pro-inflammatory cytokines like IL-1α and IL-1β influences neurodegeneration, while anti-inflammatory mediators can provide protection.
The review synthesizes current findings on cytokine roles in Alzheimer's disease, emphasizing their potential for therapeutic strategies in managing the condition.
Understanding the crosstalk between cytokines and neuroinflammation may open new avenues for effective treatments for Alzheimer's patients.